New Src Inhibitors

Catalog No. Product Name Information
F2554 Fyn Rabbit mAb
F0906 Phospho-Src (Ser 17) Rabbit mAb
F1468 Hck Rabbit mAb
F0304 Phospho-Src Family (Tyr416) Rabbit mAb Tyrosine-protein kinase Yes, Proto-oncogene c-Yes, p61-Yes, YES1, YES, Tyrosine-protein kinase Lyn, Lck/Yes-related novel protein tyrosine kinase, V-yes-1 Yamaguchi sarcoma viral related oncogene homolog, p53Lyn, p56Lyn, LYN, JTK8, Tyrosine-protein kinase Lck, LSK, Lymphocyte cell-specific protein-tyrosine kinase, Protein YT16, Proto-oncogene Lck, T cell-specific protein-tyrosine kinase, p56-LCK, Tyrosine-protein kinase HCK, Hematopoietic cell kinase, Hemopoietic cell kinase, p59-HCK/p60-HCK, p59Hck, p61Hck, Proto-oncogene tyrosine-protein kinase Src, Proto-oncogene c-Src, p60-Src, SRC, SRC1, Tyrosine-protein kinase Fyn, Proto-oncogene Syn, Proto-oncogene c-Fyn, SLK, p59-Fyn
E4630 Ilginatinib hydrochloride Ilginatinib hydrochloride (NS-018 hydrochloride) is a potent small-molecule inhibitor of JAK2 that is competitive with adenosine triphosphate (ATP) which exhibits 30–50-fold greater selectivity for JAK2 over other Jak-family kinases such as JAK1, JAK3, and TYK2.It inhibits JAK2, JAK1, JAK3, and TYK2 with IC50 of 0.72 nM, 33 nM, 39 nM, and 22 nM, respectively. It also showed potent inhibition of Src-family kinases, SRC and FYN. It can be used in research of myeloproliferative neoplasms.
All Src Inhibitors